N-(4-(Diethylaminobenzylidenyl)-N'-(4-hydroxybenzoyl)-hydrazine
CAS: 95167-41-2
Ref. 3D-VDA16741
| 1mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
N-(4-(Diethylaminobenzylidenyl)-N'-(4-hydroxybenzoyl)-hydrazine
Synonyms:
- Benzoic acid, 4-hydroxy-, [[4-(diethylamino)phenyl]methylene]hydrazide (9CI)
- Benzoic acid, 4-hydroxy-, 2-[(1E)-[4-(diethylamino)phenyl]methylene]hydrazide
- N'-{(E)-[4-(Diethylamino)phenyl]methylene}-4-hydroxybenzohydrazide
- N'-{(E)-[4-(diethylamino)phenyl]methylidene}-4-hydroxybenzohydrazide
Description:
N-(4-(Diethylaminobenzylidenyl)-N'-(4-hydroxybenzoyl)-hydrazine (MDL-28170) is a small molecule that inhibits the activity of nuclear factor-κB (NF-κB), which is a transcriptional activator of genes. It has been shown to regulate cell function and regression, as well as markers activated by NF-κB in the mitochondria, endoplasmic reticulum, and nucleus. MDL-28170 inhibits the activation of NF-κB in animal models and induces histologic regression in rats with induced prostate cancer. This agent also displays antiestrogenic effects by inhibiting the expression of estrogen receptors alpha and beta.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
311.38 g/mol
Formula:
C18H21N3O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
